Synergistic Skin Health Platform

Publication ID: 24-11857578_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Skin Health Platform,” Published Technical Disclosure No. 24-11857578_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857578_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,578.

Summary of the Inventive Concept

The Synergistic Skin Health Platform integrates a novel bacterial extract with cutting-edge technologies such as AI, IoT, blockchain, and nanomaterials to provide a comprehensive and personalized skincare solution for treating sensitive skin.

Background and Problem Solved

The original patent disclosed a novel bacterial extract for treating sensitive skin, but it had limitations in terms of monitoring skin health, providing personalized treatment recommendations, and ensuring targeted skin penetration. The Synergistic Skin Health Platform addresses these limitations by combining the bacterial extract with advanced technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The Synergistic Skin Health Platform consists of the novel bacterial extract obtained from a non-pathogenic Gram-negative bacterium belonging to the class Betaproteobacteria, subfamily Neisseriaceae, which is integrated with a blockchain-based tracking mechanism for monitoring skin health and recommending personalized skincare routines. The platform also utilizes machine learning algorithms to analyze skin data and provide personalized treatment recommendations. Additionally, the platform incorporates a wearable IoT device for monitoring skin health and providing real-time feedback on skin condition, as well as an AI-powered chatbot for providing personalized skincare advice and recommending products based on individual skin types and needs. Furthermore, the platform includes a nanomaterial-based delivery system for targeted skin penetration and absorption of the bacterial extract.

Novelty and Inventive Step

The Synergistic Skin Health Platform introduces a novel combination of the bacterial extract with advanced technologies, which provides a synergistic effect in terms of improved skin health monitoring, personalized treatment recommendations, and targeted skin penetration. The integration of these distinct technologies represents a non-obvious and innovative solution that overcomes the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the Synergistic Skin Health Platform could include the use of different types of nanomaterials, varying the design of the wearable IoT device, or incorporating additional AI-powered features such as skin condition forecasting and personalized product recommendations. The platform could also be adapted for use in other areas of dermatology, such as treating acne or aging skin.

Potential Commercial Applications and Market

The Synergistic Skin Health Platform has significant commercial potential in the skincare industry, which is projected to reach $131.8 billion by 2026. The platform's ability to provide personalized and effective skincare solutions could disrupt the traditional skincare market and appeal to consumers seeking advanced and innovative products.

Field of Art

Dermatological biotechnology, focusing on bacterial extracts for skin treatment, with expertise in microbiology, molecular biology, and advanced skincare technologies

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biotechnology or dermatological sciences, familiar with bacterial extract development, skin inflammation mechanisms, and emerging digital health technologies

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies with the bacterial extract represents a predictable application of known technological convergence strategies. The source patent's focus on treating sensitive skin provides a clear technical foundation for expanding treatment approaches through advanced monitoring and personalization technologies. The proposed platform combines well-understood technologies in a manner that would be considered routine optimization by a skilled practitioner.

Obvious Combinations & Variations

Source Patent Element
Bacterial extract for treating cutaneous neurogenic inflammation
PTD Variation
Blockchain-based tracking mechanism for monitoring skin health
Obviousness Reasoning
Integrating digital tracking with medical treatments is a known technique in personalized medicine, representing a predictable extension of existing healthcare monitoring technologies
Source Patent Element
Bacterial extract targeting sensitive skin
PTD Variation
Machine learning algorithms for personalized treatment recommendations
Obviousness Reasoning
Applying AI-driven personalization to medical treatments is a standard approach in contemporary healthcare, representing a logical and obvious technological progression
Source Patent Element
Bacterial extract with potential dermatological applications
PTD Variation
Nanomaterial-based delivery system for targeted skin penetration
Obviousness Reasoning
Advanced drug delivery techniques using nanomaterials are well-established in biotechnology, representing a predictable method for enhancing extract efficacy
Source Patent Element
Treatment method for cutaneous neurogenic inflammation
PTD Variation
IoT wearable device for real-time skin health monitoring
Obviousness Reasoning
Continuous health monitoring through wearable technologies is a known approach in digital health, representing an obvious technological integration
Source Patent Element
Bacterial extract for skin treatment
PTD Variation
AI-powered chatbot for personalized skincare advice
Obviousness Reasoning
Automated personalized healthcare recommendations are a standard application of AI technologies, representing a routine extension of existing medical consultation approaches
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857578 and the published technical disclosure, a person having ordinary skill in the art would find the proposed technological variations obvious and predictable extensions of existing bacterial extract treatment methodologies. The combination of known digital health technologies with established dermatological extract treatments represents a routine optimization that would be apparent to a skilled practitioner without requiring inventive insight.

Original Patent Information

Patent NumberUS 11,857,578
TitleExtract and dermatological composition comprising same, for treating sensitive skin
Assignee(s)PIERRE FABRE DERMO-COSMETIQUE